Why the study?
Brinzolamide-induced periocular contact dermatitis is a rare, misdiagnosed, and underrecognized adverse effect in glaucoma treatment with limited prior documentation.
Does discontinuation of brinzolamide resolve periocular contact dermatitis in glaucoma patients?
Does discontinuation of brinzolamide resolve periocular contact dermatitis in glaucoma patients?
Topical brinzolamide can cause periocular contact dermatitis, a rare adverse effect that resolves upon discontinuation of the drug.
Alerts clinicians to brinzolamide in unexplained periocular dermatitis; case reports leave open incidence and causality.
Brinzolamide-induced periocular contact dermatitis is a rare but often misdiagnosed and underrecognized adverse effect in glaucoma treatment. This case series reports three patients from a tertiary eye hospital in India who developed contact dermatitis associated with topical brinzolamide use. All patients were on multiple antiglaucoma medications. Their symptoms resolved after the discontinuation of brinzolamide. A literature review revealed limited documentation of this condition, with only one prior case report. Given the increasing use of brinzolamide, awareness of its potential dermatological side effects is essential. Early identification and drug discontinuation can prevent patient discomfort and complications, ensuring better management of glaucoma therapy.
No takes yet. Share an insight, caveat, or question.
Khimavath et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: